REG - ValiRx PLC - Update

ValiRxAnnouncement

30/03/2020 07:00

RNS Number : 9600H
  
ValiRx PLC
  
30 March 2020
  
 

ValiRx Plc
("ValiRx" or the "Company")
Update
 
London, UK. 30 March 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, provides the following update:-
 
The Company remains critically short of working capital and as previously stated is dependent on the ongoing support of its creditors in order to continue trading.
 
The Company adjourned its General Meeting which was to be held on 25 March 2020 as a result of the COVID-19 situation.
 
The Company is reviewing options available to it in order to reconvene the meeting, bearing in mind the current restrictions on public gatherings. 
 
The Company is in discussions with a number of potential funders who have indicated conditional willingness to invest in the Company in the event that resolutions are passed.
 
There is no guarantee that resolutions will be passed by shareholders at the General Meeting or that funding will ultimately be available to the Company or that creditors will be willing to extend their support to enable potential funding to occur.  A further announcement will be made in due course.
 
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
 
For more information, please contact:
 




ValiRx plc


Tel: +44 (0) 20 7073 2628
www.valirx.com




Dr Satu Vainikka, Chief Executive


Tel: +44 (0) 20 7073 2628




Tarquin Edwards, Head of Communications.


Tel: +44 (0) 7879 458 364
tarquin.edwards@valirx.com
 




Cairn Financial Advisers LLP - Nominated Adviser
 


 




Liam Murray / Jo Turner
 


Tel: +44 (0) 20 7213 0880




 


 




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
UPDDGGDXXSDDGGC